SEND V4.0 – What to Expect and When to Expect It
2025年4月24日 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
Certara2025年4月24日
Visualizing SEND Data: Why and How
Senior Director, Product Management Peggy is the Customer Success lead for SEND Explorer. She has…
Danielle Pillsbury2025年4月21日
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
2025年2月24日 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
Certara2025年2月24日
The Benefits of Real-Time Nonclinical Safety Data Analysis
Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…
Danielle Pillsbury2025年1月27日
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know
2024年12月3日 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…
Certara2024年12月3日
Transforming Non-clinical Drug Development with SEND Explorer
Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…
Danielle Pillsbury2024年7月8日
What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
Danielle Pillsbury2023年6月12日
Data Visualization with SEND Data to See What Happened at the Preclinical Phase
SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…
Danielle Pillsbury2023年2月9日
